Great idea in regard to Prof Miles Prince and the media, but l think we should wait another couple of months as the Oncology Unit at the Freemasons Hospital has only just started dosing their first patient. Soon our other two locations will be active as well and PTX100 will be treating 40 patients, l am also looking forward to hearing from Prof Phil Darcy from The Sir Peter MacCallum Department of Oncology in regard to our Cell Therapy: Omni Car. Let's not forget the Omni Car platform as it seeks to overcome the challenges of conventional Car-t therapy including manufacturing / safety & reliability. Omni Car is a modular, universal CAR platform based on technology licensed from UPenn & Oxford University. It allows unprecedented control and flexibility over current generation CAR-T approaches. This treatment at this stage has concentrated on mainly on Breast Cancer but l am fairly confident they are exploring solid Tumer as well. I am not confused that OMNI Car is around the corner but its market potential is immense in comparison to PTX100. PTX in general has enormous potential.
Add to My Watchlist
What is My Watchlist?
